The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Interaction between tumour‐infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
Open accessAbstract
Objective: The nature of the tumour-infiltrating leucocytes (TILs) is known to impact clinical outcome in carcinomas, including hepatocellular carcinoma (HCC). However, the role of tumour-infiltrating B cells (TIBs) remains controversial. Here, we investigate the impact of TIBs and their interaction with T cells on HCC patient prognosis. Design: Tissue samples were obtained from 112 patients with HCC from Singapore, Hong Kong and Zurich and analysed using immunohistochemistry and immunofluorescence. RNA expression of CD19, CD8A, IFNG was analysed using quantitative PCR. The phenotype of freshly isolated TILs was analysed using flow cytometry. A mouse model depleted of mature B cells was used for functional study. Results: Tumour-infiltrating T cells and B cells were observed in close contact with each other and their densities are correlated with superior survival in patients with HCC. Furthermore, the density of TIBs was correlated with an enhanced expression of granzyme B and IFN-γ, as well as with reduced tumour viability defined by low expression of Ki-67, and an enhanced expression of activated caspase-3 on tumour cells. CD27 and CD40 costimulatory molecules and TILs expressing activation marker CD38 in the tumour were also correlated with patient survival. Mice depleted of mature B cells and transplanted with murine hepatoma cells showed reduced tumour control and decreased local T cell activation, further indicating the important role of B cells. Conclusions: The close proximity of tumour-infiltrating T cells and B cells indicates a functional interaction between them that is linked to an enhanced local immune activation and contributes to better prognosis for patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, liver B cells might play multifaceted roles given that several studies show that patients with HCC with increased infiltration of total B cells have a favorable prognostic outcome.( 77 , 78 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [78]
In the citing paper
“In addition, in mice transplanted with murine hepatomas or diethylnitrosamine‐induced cancer, tumor growth was enhanced when all B cells were depleted.( 78 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Lineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Stack, E. C., Wang, C., Roman, K. A., & Hoyt, C. C. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.016 · Cited by 768
Kurosaki, T., Kometani, K., & Ise, W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3802 · Cited by 691
Nielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
The Role of CD40 Ligand in Costimulation and T‐Cell Activation
Grewal, I. S., & Flavell, R. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00921.x · Cited by 449
CD27 and CD70 in T cell and B cell activation
Borst, J., Hendriks, J., & Xiao, Y. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.04.004 · Cited by 419
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Nelson, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001323 · Cited by 416
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Tan, W. C. C., Nerurkar, S. N., Cai, H. Y., Ng, H. H. M., Wu, D., Wee, Y. T. F., Lim, J. C. T., Yeong, J., & Lim, T. K. H. (2020) · Cancer Communications · doi:10.1002/cac2.12023 · Cited by 678
Self-citationFridman, W. H., Meylan, M., Petitprez, F., Sun, C.-M., Italiano, A., & Sautès-Fridman, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00619-z · Cited by 657
Metadata
- Authors
- Garnelo, M., Tan, A., Her, Z., Yeong, J., Lim, C. J., Chen, J., Lim, K. H., Weber, A., Chow, P., Chung, A., Ooi, L. L. P., Toh, H. C., Heikenwalder, M., Ng, I. O. L., Nardin, A., Chen, Q., Abastado, J.-P., & Chew, V.
- Affiliations
- Agency for Science, Technology and Research (SG)
- SingHealth (SG)
- Singapore General Hospital (SG)
- University Hospital Zurich (CH)
- National University of Singapore (SG)
- National Cancer Centre Singapore (SG)
- Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Queen Mary Hospital (CN)
- Corresponding author
- Chew, Valerie
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-12-15
- Volume
- 66
- Issue
- 2
- Pages
- 342-351
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC5284473
- OpenAlex
- W2204209053
- Cited by
- 461
- References
- 43
- Citations by year
- 2026: 21 · 2025: 36 · 2024: 51 · 2023: 66 · 2022: 60 · 2021: 88 · 2020: 55 · 2019: 30 · 2018: 25 · 2017: 19 · 2016: 10
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Site cant be reached (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Agency for Science, Technology and Research
- Servier
- Partenariat Canadien Contre Le Cancer
- Genentech
- Medical Research Council
- National Medical Research Council
- Biomedical Research Council
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- hepatocellular carcinoma, tumor-infiltrating T cells, T cell-B cell interaction, prognosis, granzyme B, interferon-gamma, CD27, CD40, CD38, B-cell depletion, tumor immune microenvironment, caspase-3, Ki-67
- MeSH terms
- Adult, Aged, Aged, 80 and over, Animals, B-Lymphocytes, Female, Carcinoma, Hepatocellular, Humans, Interferon-gamma, Liver Neoplasms, Lymphocyte Depletion, Male, Mice, Inbred C57BL, Middle Aged, Phenotype, Retrospective Studies, T-Lymphocytes, Antigens, CD, Gene Expression, Survival Rate, Lymphocytes, Tumor-Infiltrating, CD8 Antigens, CD3 Complex, Tumor Necrosis Factor Receptor Superfamily, Member 7, Disease Progression, Antigens, CD19, Antigens, CD20, CD40 Antigens, Ki-67 Antigen, Mice, ADP-ribosyl Cyclase 1, Caspase 3, Granzymes, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interaction between tumour‐infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1136/gutjnl-2015-310814
- The paper
- Garnelo, M., Tan, A., Her, Z., Yeong, J., Lim, C. J., Chen, J., Lim, K. H., Weber, A., Chow, P., Chung, A., Ooi, L. L. P., Toh, H. C., Heikenwalder, M., Ng, I. O. L., Nardin, A., Chen, Q., Abastado, J.-P., & Chew, V. (2017). Interaction between tumour‐infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. https://doi.org/10.1136/gutjnl-2015-310814
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.